7-hydroxy-6-methyl-8-(1-D-ribityl)lumazine

Metabolite details

Identifier

COXMGTTXHPRZBO-BBVRLYRLSA-N

InChI Key

COXMGTTXHPRZBO-BBVRLYRLSA-N

IUPAC name

1-deoxy-1-(7-hydroxy-6-methyl-2,4-dioxo-3,4-dihydropteridin-8(2H)-yl)-D-ribitol

Preferred name

7-hydroxy-6-methyl-8-(1-D-ribityl)lumazine

INN name

—

Synonym

Masuda's compound V

ChEBI

CHEBI:27581

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Control_vs_Paramycin
• Control_vs_Lithogenic_Diet
• Sham_vs_Radiofrequency
• Control_vs_CSD
• Male_19_days_vs_Male_1_day
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT